Search

Henry M Smilowitz

from West Hartford, CT
Age ~78
Get Report
Also known as:
Henry Dr Smilowitz, Henry Z
Phone and address:
31 Quaker Ln, Hartford, CT 06119
(860) 841-1673
Related to:
Agron Cela
Connected to:
Ben S Smilowitz, 43Martin M Smiltneek, 75Julie K Smily, 55Michael T Sminia, 64David E Smink, 89Jonathan S Smink, 45Laura M Smink, 99Robert D Smink, 84Brittany M Sminkey, 28David R Sminkey, 62

Henry Smilowitz Phones & Addresses

  • 31 Quaker Ln, West Hartford, CT 06119 (860) 841-1673
  • Hartford, CT
  • 31 Quaker Ln N, West Hartford, CT 06119

Work

Company: Uconn health Oct 1976 Position: Associate professor and basic sci

Industries

Hospital & Health Care

Resumes

Resumes

Henry Smilowitz Photo 1

Associate Professor And Basic Sci

View page
Location:
31 Quaker Ln south, West Hartford, CT 06119
Industry:
Hospital & Health Care
Work:
Uconn Health
Associate Professor and Basic Sci

Business Records

Name / Title
Company / Classification
Phones & Addresses
Henry Smilowitz
Associate Professor/basic Sci Diag Imaging And Therapeutics
The University of Connecticut Research and Development Corporation
General Hospital College/University
263 Farmington Ave, Farmington, CT 06032
263 Farmington Ave, New Britain, CT 06032
(860) 679-2000, (860) 679-1255, (860) 832-4664

Publications

Us Patents

Cancer Immunotherapy Improved By Prior Radiotherapy

View page
US Patent:
20010055589, Dec 27, 2001
Filed:
Aug 16, 2001
Appl. No.:
09/931440
Inventors:
Henry Smilowitz - West Hartford CT, US
Daniel Slatkin - Southold NY, US
Assignee:
University of Connecticut
International Classification:
A61K048/00
US Classification:
424/093700, 424/093210
Abstract:
A method of optimizing malignancy therapy includes surgical removal or reduction of the body burden of malignant cells and retention of some of those cells for subsequent use in immunotherapy. Radiotherapy may be employed at a radiation dosage below the threshold for normal tissue necrosis but on a correspondingly faster schedule than is the present United States standard to provide preservation of normal tissue structure. Normal tissue tolerable limits for one fraction are in the range of 10-13 Gy or Gy-Eq. The removed tumor cells are altered genetically to enhance their immunogenicity and also altered ex vivo by radiation or by any other means to render them incapable of sustained clonogenic propagation and then are re-injected using multiple sequenced injections.

Method For Improvement Of Radiation Therapy Of Malignant Tumors

View page
US Patent:
62998730, Oct 9, 2001
Filed:
Jun 16, 1999
Appl. No.:
9/334312
Inventors:
Henry M. Smilowitz - West Hartford CT
Jeffrey A. Coderre - Wading River NY
Daniel N. Slatkin - Southold NY
Assignee:
University of Connecticut - Farmington CT
International Classification:
A61K 3500
A61K 4800
A61K 3512
C12N 1585
C12N 1563
US Classification:
424 937
Abstract:
A method of optimizing malignancy therapy includes surgical removal or reduction of the body burden of malignant cells and retention of some of those cells for subsequent use in immunotherapy. Boron neutron-capture therapy is employed at a radiation dosage below the threshold for normal tissue necrosis to provide preservation of normal tissue structure. Normal tissue tolerable limits are in the range of 10-13 GY-Eq. The removed tumor cells are altered by radiation or genetically to render them incapable of unlimited clonogenic propagation and then reinjected using multiple sequenced injections.
Control profile
Henry M Smilowitz from West Hartford, CT, age ~78 Get Report